Abstract The intralesional use of corticosteroids is presently an important form of dermatologic therapy. A mixture of betamethasone disodium phosphate and betamethasone acetate has been evaluated after its intralesional use in certain dermatologic conditions. Five hundred twenty patients were treated and an average of 82% of these improved after injection. Two percent of the patients became worse while under treatment and of the entire group only five noted any type of adverse reaction. At the present time, this preparation appears to be one of the more valuable agents for local intralesional or sublesional dermatologic use. Clinically it compares favorably with other similar compounds and in this study systemic reactions were few and local complications were absent. References 1. Goldman, L.: Reactions Following Intralesional and Sublesional Injections of Corticosteroids , JAMA 182:613-616 ( (Nov 10) ) 1962.Crossref
Archives of Dermatology – American Medical Association
Published: Apr 1, 1966
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera